Prostate Cancer Survival
Prostate Cancer Survival – www.medical-research-study-directory.info Life after Prostate Cancer surgery This is video #26 in the series on One prostate cancer patient’s views & opinions after prostate cancer surgery. This video, #26, was made two years after my robotic radical prostatectomy. In this type of prostate cancer surgery the surgeon moves the robotic arm while sitting at a computer monitor near the operating table. The nerve bundles on either side of the prostate are responsible for erections and if they appear to be cancer-free, the surgeon usually will not remove them. This modified operation is called a nerve-sparing radical prostatectomy. After my prostate cancer surgery, the pathology report on the removed prostate gland was good, but my surgeon always has the fatty tissue that is around the prostate gland analyzed (most doctors do NOT have this done), it turned out in my case, that prostate cancer was found in the lymph nodes of this tissue. So, unfortunately for me, I ended up with stage four prostate cancer. Again, in my case, the recommended course of action was hormone therapy, not to kill the cancer (there is no cure for prostate cancer) but to slow its progress. Testosterone deprivation therapy is also known as androgen deprivation therapy (ADT). Testosterone increases beyond the castrate level have been shown to increase the rate of spread of an existing prostate cancer. Usually, at some point, the prostate cancer is no longer affected by the …
Read the original here: Prostate Cancer Survival
Enzyme corrects more than one million faults in DNA replication
Scientists have discovered that one enzyme corrects more than one million faults in DNA replication. And, it corrects the most common mistake in mammalian DNA.
Original post: Enzyme corrects more than one million faults in DNA replication
Coffee drinkers have lower risk of death, study suggests
Older adults who drank coffee — caffeinated or decaffeinated — had a lower risk of death overall than others who did not drink coffee, according a new study.
Link: Coffee drinkers have lower risk of death, study suggests
Insomnia and its treatment in women with breast cancer.
Sleep medicine reviews , Vol. 10, No. 6. , pp. 419-429, doi:10.1016/j.smrv.2006.03.005 Insomnia is a common complaint in breast cancer patients and has been shown to have a host of psychological and medical correlates and consequences.
Excerpt from: Insomnia and its treatment in women with breast cancer.
Cancer Foundation hosts benefit luncheon
The Ryan Lee Holland Cancer Foundation luncheon is being called “The Gathering of Hope.”A The event features a luncheon, silent auction and raffle.
View post: Cancer Foundation hosts benefit luncheon
Pet Cancer Awareness Month Helps Teach Owners about Leading Cause of Death
As the month of May gets underway, so does Pet Cancer Awareness Month. This month is designed to bring awareness to pet owners about the leading cause of death in pets, cancer.
Excerpt from: Pet Cancer Awareness Month Helps Teach Owners about Leading Cause of Death
Ohio boys share school, Cub Scouts, cancer battles
Then, weeks went by before Alex could go outside. He was a patient at Toledo Children’s Hospital, his window overlooking offices and a roof, as the weather warmed.
Excerpt from: Ohio boys share school, Cub Scouts, cancer battles
Georgetown University study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. That kind of information is behind a novel clinical trial at Georgetown Lombardi Comprehensive Cancer Center that combines cetuximab and lapatinib. Findings from this phase I study will be presented at the American Society of Clinical Oncology annual meeting in Chicago, June 1st through 5th.
Read the original: Georgetown University study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
In Georgetown University phase I study, combination of temsirolimus, temsirolimus proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive Cancer Center researchers conducting the study in cancer patients whose tumors have resisted multiple treatments say the combination demonstrates “promising evidence” of disease control and should be studied in a phase II trial. Their clinical findings and additional data from the study will be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, June 1 through 5, 2012.
Original post: In Georgetown University phase I study, combination of temsirolimus, temsirolimus proves safe; positive survival trend seen
University of Colorado study associates protein RAL with aggressive characteristics in prostate, bladder and skin cancers
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers – an essential step on the path to developing drugs to target these proteins. From metastasis in bladder cancer, to seminal vessel involvement in prostate cancer, to shortened survival in squamous cell carcinoma, a study published this week in the journal Cancer Research shows that proteins RalA and RalB are associated with aggressive cancer characteristics in human tumors.
Go here to see the original: University of Colorado study associates protein RAL with aggressive characteristics in prostate, bladder and skin cancers